Dante Labs announces expansion of its Whole Genome Sequencing test with enhanced and broader offering
NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) — Dante Labs, a global leader in genomics and precision medicine, today announced the expansion of its Dante 30X Whole Genome Sequencing Test with personalized interpretation leveraging Dante’s proprietary Extensa Software Platform. The expanded offering includes sequencing in Dante’s clinically validated and authorized labs. Notable improvements include: enhanced […]